García-Roman, S., Garzón-Ibáñez, M., Bertran-Alamillo, J., Jordana-Ariza, N., Giménez-Capitán, A., García Peláez, B., . . . Molina Vila, M. Á. (2024). Vaccine antibodies against a synthetic epidermal growth factor variant enhance the antitumor effects of inhibitors targeting the MAPK/ERK and PI3K/Akt pathways.
Citación estilo ChicagoGarcía-Roman, Sílvia, et al. Vaccine Antibodies against a Synthetic Epidermal Growth Factor Variant Enhance the Antitumor Effects of Inhibitors Targeting the MAPK/ERK and PI3K/Akt Pathways. 2024.
Cita MLAGarcía-Roman, Sílvia, et al. Vaccine Antibodies against a Synthetic Epidermal Growth Factor Variant Enhance the Antitumor Effects of Inhibitors Targeting the MAPK/ERK and PI3K/Akt Pathways. 2024.
Precaución: Estas citas no son 100% exactas.